Displaying 641 - 660 of 853
| Active Ingredient | HYDROCORTISONE SODIUM SUCCINATE |
| Therapeutic Class | ADRENALS |
| Indications | See Hydrocortisone.For anti inflammatory action, e.g. connective tissue disorders, chronic active hepatitis, allergic disorders. |
| Caution |
hypertension sodium retention water retention potassium loss calcium loss |
| Dose Range | Adult: i.m., slow i.v. inj. Or infusion: 100-500mg, 3-4 times in 24 hrs. Pediatric: neonates: 10 mg as a slow inj. Then 100 mg/m2/day as a continuous infusion or in divided doses every 6-8 hrs; reduced over 4-5 day s to an oral maintenance dose. 1 |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | METHYLPREDNISOLONE |
| Therapeutic Class | ADRENALS |
| Indications | See Hydrocortisone. |
| Caution | See Hydrocortisone. |
| Dose Range |
Adult: i.m. slow i.v. injection or infusion 10-500mg. Pediatric: 0.5-1.7mg/kg every 6-12 hours. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | METHYLPREDNISOLONE SODIUM SUCCINATE |
| Therapeutic Class | ADRENALS |
| Indications | See Hydrocortisone.For anti inflammatory action, e.g. connective tissue disorders, chronic active hepatitis, allergic disorders. |
| Caution | See Hydrocortisone.Hypertension, sodium retention and potassium loss, diabetes, muscle weakness and myopathy, osteoporosis, mental changes, gastrointestinal upset and peptic ulcer; growth retardation More ... |
| Dose Range | See Methylprednisolone Acetate.Adult:i.m. slow i.v. injection or infusion 10-500mg. Pediatric: 0.5-1.7mg/kg every 6-12 hours. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | PREDNISOLONE |
| Therapeutic Class | ADRENALS |
| Indications |
Drug of choice for most conditions requiring oral corticosteroids, for anti-inflammatory action, e.g. connective tissue disorders, chronic active hepatitis, ulcerative colitis, myasthenia gravis. |
| Caution | Hypertension, sodium retention and potassium loss, diabetes, muscle weakness and myopathy , osteoporosis, mental changes, gastro-intestinal up set and peptic ulcer; growth retardation in ch More ... |
| Dose Range | Adult: 2.5- 60 mg daily in divided doses, as a single daily dose after breakfast, or as a double dose on alternate days. Pediatric: 1 month to 18 y rs:1-2mg/kg/day (M ax. 60mg/day ), then reduce after a few days if appropriate. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | TRIAMCINOLONE |
| Therapeutic Class | ADRENALS |
| Indications | See Hydrocortisone. |
| Caution | Avoid in chronic use. |
| Dose Range | 40mg repeated at intervals. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DANAZOL |
| Therapeutic Class | ANDROGENS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | TESTOSTERONE |
| Therapeutic Class | ANDROGENS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | COPPER-T |
| Therapeutic Class | CONTRACEPTIVES |
| Indications | Intrauterine devices (IUDs) are small contraceptive devices that are inserted into the uterus (womb) to prevent pregnancy. |
| Caution | Abdominal pain lower; anaemia; back pain; device complications; menstrual cycle irregularities; pelvic inflammatory disease; uterine injuries. |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | CYPROTERONE | ETHINYL ESTRADIOL |
| Therapeutic Class | CONTRACEPTIVES |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DROSPIRENONE | ETHINYL ESTRADIOL |
| Therapeutic Class | CONTRACEPTIVES |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | ETHINYL ESTRADIOL | DROSPIRENONE |
| Therapeutic Class | CONTRACEPTIVES |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | ETHINYL ESTRADIOL | GESTODENE |
| Therapeutic Class | CONTRACEPTIVES |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | LEVONORGESTREL |
| Therapeutic Class | CONTRACEPTIVES |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | LYNESTRENOL |
| Therapeutic Class | CONTRACEPTIVES |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | MEDROXYPROGESTERONE |
| Therapeutic Class | CONTRACEPTIVES |
| Indications | Long-acting contraceptive. |
| Caution | Fluid retention, weight changes. |
| Dose Range | 150mg every 12 weeks for contraception. The first injection for contraception must be given ONLY during the first 5 days of a normal menstrual period, ONLY within the first 5-days postpartum if not breast feeding; and if exclusively breastfeeding |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | CONDOM |
| Therapeutic Class | CONDOMS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DIENOGEST | ESTRADIOL |
| Therapeutic Class | ESTROGENS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DROSPIRENONE | ESTRADIOL |
| Therapeutic Class | ESTROGENS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | ESTRADIOL |
| Therapeutic Class | CONJUGATED EQUINE ESTROGENS |
| Indications | HRT (maybe cyclical and progestogen should be added for 10-14 days of the cycle or may be continuously combined). Prevention of post-menopausal osteoporosis and vascular disease. Atrophic vaginitis; a More ... |
| Caution | Less thromboembolic disease than semisyntheticor synthetic oestrogen, spotting, breast tenderness,chloasma, weight changes. c.f. prescribing in liver disease p. 16. |
| Dose Range | Oral: 0.5-2mg daily. Vaginal: 2-4g (0.2-0.4mg oestradiol) daily for 1-2 weeks, then increase to 1-2g/day for 1-2 weeks; then maintainance dose of 1g 1-3 times weekly for 3 weeks, then off for 1 week; then repeat cycle once vaginal mucosa has been restored |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | ESTRIOL |
| Therapeutic Class | ESTROGENS |
| Indications | Hormone repalcement therapy for the treatment of lower genitourinary tract atrophy associated with estrogen deficiency, either in female climacteric or after surgical castration, which produce vagina More ... |
| Caution | breast discomfort and pain,vagianl discharge, irrtation and itch on application sites , headache, |
| Dose Range | For |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |